Intelligent Secret Port System: An Integrated Bio-Vital Geometric Vision for Extracorporeal Blood Filtration

This normative conceptual framework introduces the Intelligent Secret Port System (ISPS), a geometrically optimized, bio-vital hybrid vascular interface exploiting native transmural pressure gradients in the retroperitoneal space at the L4--L5 level for on-demand hemofiltration. Recent evidence confirms that catheter-related bloodstream infections (CRBSI) account for up to 70% of vascular access infections in hemodialysis, with rates ranging from 0.18 to 11.3 per 1,000 catheter-days globally, and a pooled relative risk reduction of 63% with antibiotic lock solutions. Survival disparities remain stark: 7-year survival of 65.5% for arteriovenous fistulae (AVF) versus 26.4% for tunneled central venous catheters (CVC). Rigorous multi-physics derivations are presented with full analytical transparency: (i) reduction of the incompressible Navier--Stokes equations to the exact Hagen--Poiseuille solution under stated assumptions, with formal Reynolds-number proof of laminar regime (Re=1025); (ii) wall-shear-stress analysis yielding τ_w = 2.36 Pa; (iii) Womersley-number characterization (α ≈ 3.8) confirming quasi-steady applicability; and (iv) Kedem--Katchalsky convective-diffusive mass transport with explicit parameterization leading to a first-principles Kt/V derivation of approximately 1.31. Advanced three-dimensional computational fluid dynamics and finite-element analysis (CFD/FEA) using ANSYS Fluent 2024 R2 and Mechanical, incorporating non-Newtonian blood rheology (full Carreau--Yasuda model, patient-specific parameters), one-way fluid--structure interaction, pulsatile inlet boundary conditions, and thrombogenicity quantification (Bluestein index), indicate potential physiological compatibility. Comprehensive uncertainty quantification via Sobol' variance decomposition (with bootstrap confidence intervals), Bayesian parameter inference (Metropolis--Hastings MCMC, 10,000 post-burn-in samples), Polynomial Chaos Expansion (PCE, degree-4 surrogate with R²>0.9995), and extended patient-specific scenario analysis rigorously quantifies parameter sensitivities and robustness. Systematic risk analysis (FMEA per ISO 14971:2019) and a biocompatibility roadmap (ISO 10993-1:2018) address potential complications. Verification and validation follow the ASME V&V 20-2019 framework with Grid Convergence Index (GCI) assessment. The ISPS is explicitly designed as the enabling vascular interface for next-generation wearable artificial kidney systems, delivering pump-free, ambulatory hemofiltration. All data, executable code, and supplementary materials are self-contained within this paper to ensure full reproducibility. This work is purely conceptual and theoretical; no physical prototypes, animal studies, or human data were involved.